The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study to Assess the Relative Bioavailability of Process Variants of Selumetinib in Healthy Male Volunteers
Official Title: A Phase I, Single Centre, Randomised, Open Label, Crossover Study to Assess the Bioequivalence or Relative Bioavailability of Variants of Selumetinib (AZD6244, Hyd-Sulfate) Blue Capsules in Healthy Male Volunteers Aged 18 to 45 Years
Study ID: NCT02322749
Brief Summary: A Study to assess, against a reference selumetinib capsule, if the drug levels of a variant of selumetinib capsule are comparable, and to assess how drug levels differed in another variant of Selumetinib in Healthy Male Volunteers.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: MALE
Healthy Volunteers: Yes
Research Site, London, , United Kingdom
Name: Olufeyikemi Oluwayi, MBChB
Affiliation: Quintiles, Inc.
Role: PRINCIPAL_INVESTIGATOR